Assignee
SERAGEN INC
US·9 granted patents·596 citations·filing 1990–1997
Top patents by PatentIndex Score
9 records- 0195US6022950AHybrid molecules having translocation region and cell-binding regionSERAGEN INC·Filed 1995·Granted Feb 8, 2000·131 cites·51 claims
- 0295US5668255AHybrid molecules having translocation region and cell-binding regionSERAGEN INC·Filed 1993·Granted Sep 16, 1997·182 cites·20 claims
- 0393US5965406ARecombinant DNAS encoding three-part hybrid proteinsSERAGEN INC·Filed 1995·Granted Oct 12, 1999·89 cites·51 claims
- 0485US6074636AMethod of using cell surface receptor targeted molecules for the treatment of viral diseasesSERAGEN INC·Filed 1995·Granted Jun 13, 2000·110 cites·20 claims
- 0575US5906820AEpidermal growth factor receptor targeted molecules for treatment of inflammatory arthritisSERAGEN INC·Filed 1997·Granted May 25, 1999·38 cites·20 claims
- 0668US5614488AEpidermal growth factor receptor targeted molecules for treatment of inflammatory arthritisSERAGEN INC·Filed 1993·Granted Mar 25, 1997·22 cites·14 claims
- 0761US5571507AMethods of treating diabetesSERAGEN INC·Filed 1992·Granted Nov 5, 1996·23 cites·14 claims
- 0831US5110912APurification of il-2-containing hybrid compoundsSERAGEN INC·Filed 1990·Granted May 5, 1992·1 cites·9 claims
- 0918US5684221AMammalian model of a malignant disorderSERAGEN INC·Filed 1994·Granted Nov 4, 1997·0 cites·11 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →